Abstract | OBJECTIVE: METHOD: Twenty cases of nasal polyps were selected. Fluticasone propionate were intranasally used in 10 cases of nasal polyps for 7-10 days before operation. The others, treated with nothing, were used as control. Twenty samples nasal polyps were obtained and studied with immunochemistric technique. RESULT: The expression of AQP-5 positive cells in the blood vessel endothelium was statistically significantly redueced in the Fluticasone propionate-using group compared with the control group (P < 0.05). The difference of AQP-5 positive cells in mucosal epithelial and glandular epithelium was not statistically significant between the Fluticasone propionate-using group and the control group. CONCLUSION: (1) AQP-5 might be a vital factor for the formation edema of nasal polyps. (2) The effects of Fluticasone propionate on nasal polyps may be related to changing the expression of AQP-5 to a degree. (3) The full exploration of regulation and control of Aquaporions can contribute to evaluate the pathogenesis of nasal polyps.
|
Authors | Zhihai Li, Qixue Gao, Hongtao Zhen, Yonghua Cui |
Journal | Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology
(Lin Chuang Er Bi Yan Hou Ke Za Zhi)
Vol. 18
Issue 11
Pg. 647-9
(Nov 2004)
China |
PMID | 15715403
(Publication Type: English Abstract, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Androstadienes
- Anti-Inflammatory Agents
- Aquaporin 5
- Fluticasone
|
Topics |
- Administration, Intranasal
- Adult
- Androstadienes
(administration & dosage, therapeutic use)
- Anti-Inflammatory Agents
(administration & dosage, therapeutic use)
- Aquaporin 5
(biosynthesis)
- Female
- Fluticasone
- Humans
- Male
- Middle Aged
- Nasal Polyps
(drug therapy, metabolism)
|